Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study

Peer Review reports

Original Submission
11 Oct 2012	Submitted	Original manuscript
12 Dec 2012	Reviewed	Reviewer Report - Miguel Piris
20 Dec 2012	Reviewed	Reviewer Report - JUAN F GARCIA
21 Jan 2013	Author responded	Author comments - Anna Sebestyén
Resubmission - Version 2
21 Jan 2013	Submitted	Manuscript version 2
29 Jan 2013	Reviewed	Reviewer Report - JUAN F GARCIA
10 Feb 2013	Reviewed	Reviewer Report - Miguel Piris
2 Apr 2013	Author responded	Author comments - Anna Sebestyén
Resubmission - Version 3
2 Apr 2013	Submitted	Manuscript version 3
Publishing
25 Apr 2013	Editorially accepted
22 May 2013	Article published	10.1186/1471-2407-13-250

Back to article page